Financials
- Market Capitalization 8.07 M
- Employee 8
- Founded 2017
- CEO N/A
- Website www.cnspharma.com
- Headquarter Nevada, United States
- FIGI BBG00PM24T16
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4810 | XCUR Exicure, Inc. - Common Stock | 1.29 USD | -8.51% | +9.32% | -25.86% | -75.57% | 8.44 M USD | ||
| 4814 | SNGX Soligenix, Inc. - Common Stock | 0.38 USD | 0.00% | -7.32% | +2.70% | -66.37% | 8.27 M USD | ||
| 4821 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.66 USD | -0.60% | +9.93% | +24.81% | -32.52% | 7.95 M USD | ||
| 4823 | AIM AIM ImmunoTech Inc. Common Stock | 0.26 USD | +4.00% | 0.00% | +8.33% | -89.65% | 7.91 M USD |
Frequently asked questions about CNS Pharmaceuticals, Inc. Common Stock
What is the CNS Pharmaceuticals, Inc. Common Stock stock price today?
The current price of CNS Pharmaceuticals, Inc. Common Stock (CNSP) is 5.52. Over the past 24 hours, the stock has changed by 0.00%. Follow the CNSP chart for real-time price dynamics.
What is the stock ticker of CNS Pharmaceuticals, Inc. Common Stock?
CNS Pharmaceuticals, Inc. Common Stock trades under the ticker CNSP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CNS Pharmaceuticals, Inc. Common Stock stock going up?
CNSP has changed by -3.16% over the last week, +13.81% over the last month, and -10.97% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of CNS Pharmaceuticals, Inc. Common Stock?
CNS Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 8.07 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were CNS Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, CNS Pharmaceuticals, Inc. Common Stock reported earnings of -0.38 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was CNS Pharmaceuticals, Inc. Common Stock net income for the last quarter?
CNS Pharmaceuticals, Inc. Common Stock reported net income of -2.59 M for the last quarter. The previous quarter showed -4.94 M, which means net income changed by +47.58%.
How many employees does CNS Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, CNS Pharmaceuticals, Inc. Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy CNS Pharmaceuticals, Inc. Common Stock stock?
You can buy CNS Pharmaceuticals, Inc. Common Stock (CNSP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CNS Pharmaceuticals, Inc. Common Stock stock?
Investing in CNS Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CNSP chart and related analysis on metatrader.com as part of your research.